COL11A1 and ductal breast carcinoma in situ: In the Toss et al. study [80], increased immunohistochemical staining was discovered in mixed DCIS-IBC (n = 239) cases compared to the pure DCIS cases (n = 776) with invasive regions reporting the highest expression of COL11A1.